Floatz logo

om-89 [uro-vaxom® ]

Chronic Prostatitis

AJU Pharm Co., Ltd.Phase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Chronic Prostatitis cohort.

Asset / SponsorPhaseRating
Ningmitai
Xintian Pharmaceutical
Phase 4BBB
Selenium
Clinica Urologica Molinette - Città della Saliute e della Scienza
Phase 4BB
PALMITIC MONOETHANOLAMIDE
Clinica Urologica Molinette - Città della Saliute e della Scienza
Phase 4BB
Serenoa repens extract
Clinica Urologica Molinette - Città della Saliute e della Scienza
Phase 4BB
Tamsulosin
Xintian Pharmaceutical
Phase 4BB

View all 20 →

Same molecule, other indications

om-89 [uro-vaxom® ] is also rated in:

Chronic Prostatitis With Chronic Pelvic Pain SyndromeDormant
BB
Indicative ·
65 / 100
View asset →
Chronic Pelvic Pain SyndromeDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →